Efferent Labs selected as a finalist in the 43North Business competition
Raland Therapeutics Inc. was selected as a semi-finalist in the 43North Business competition.
July 15, 2014
NEWS AND EVENTS
Amazing blog post
News
Efferent Labs selected as a finalist in the 43North Business competition
Raland Therapeutics Inc. was selected as a semi-finalist in the 43North Business competition. From almost 7,000 applicants, RTI was reviewed and was selected to be among the 113 top entries.
July 15, 2014
CytoComm™ Living Biosensor to be presented the at SmartStart Venture Forum®
Contact: Mike Barra (mbarra@ralandcorp.com)
Direct Phone: 585-598-1180 ext. 740
April 29, 2013
Big Potential: Startup Raland Therapeutics and its small living-cell monitoring device have drawn some notable names to its board.
Raland Therapeutics Inc. held its first in-person board meeting last weekend, drawing a cast of luminaries to the startup biotech firm’s Perinton headquarters.
May 25, 2012
Events
Our transformative technology platform will dramatically reduce R&D costs.